- $904.42m
- $616.33m
- $76.99m
Annual income statement for Geron, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.253 | 1.39 | 0.596 | 0.237 | 77 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 75.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 77.2 | 115 | 139 | 194 | 252 |
| Operating Profit | -76.9 | -114 | -139 | -194 | -175 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -75.6 | -116 | -142 | -184 | -175 |
| Net Income After Taxes | -75.6 | -116 | -142 | -184 | -175 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -75.6 | -116 | -142 | -184 | -175 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -75.6 | -116 | -142 | -184 | -175 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.279 | -0.354 | -0.373 | -0.323 | -0.268 |